WO1998031301A1 - Device for genuine stress incontinence in the female - Google Patents
Device for genuine stress incontinence in the female Download PDFInfo
- Publication number
- WO1998031301A1 WO1998031301A1 PCT/IB1997/000670 IB9700670W WO9831301A1 WO 1998031301 A1 WO1998031301 A1 WO 1998031301A1 IB 9700670 W IB9700670 W IB 9700670W WO 9831301 A1 WO9831301 A1 WO 9831301A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluid
- periurethral
- cuff
- bladder neck
- periurethral cuff
- Prior art date
Links
- 206010066218 Stress Urinary Incontinence Diseases 0.000 title claims description 11
- 208000022170 stress incontinence Diseases 0.000 title claims description 10
- 239000012530 fluid Substances 0.000 claims abstract description 17
- 210000003708 urethra Anatomy 0.000 claims abstract description 17
- 230000001965 increasing effect Effects 0.000 claims abstract description 11
- 210000003195 fascia Anatomy 0.000 claims abstract description 6
- 230000000284 resting effect Effects 0.000 claims abstract description 5
- 206010021639 Incontinence Diseases 0.000 claims description 5
- 210000003903 pelvic floor Anatomy 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 210000003739 neck Anatomy 0.000 abstract description 12
- 210000004197 pelvis Anatomy 0.000 abstract description 4
- 239000000560 biocompatible material Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 210000003689 pubic bone Anatomy 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000011848 urodynamic investigation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
- A61F2/004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable inflatable
Definitions
- This device relates to an implant for the treatment of genuine stress urinary incontinence in the female.
- Stress incontinence is urine loss that occurs when sudden increase in intra-abdominal pressure force urine past the urethral sphincter mechanism. This usually occurs during conditions of physical activity which stress the bladder outlet to such a degree that it can no longer remain closed, resulting a momentary urine loss. This is a common and distressing condition.
- This implantable continence device consists of a hydraulic and a mechanical component.
- the hydraulic component comprises of two retropubic subperitoneal fluid filled balloon reservoirs 1 which communicates with a periurethral cuff 2 to form a complete hydraulic system.
- a fluid outlet channel 4 At the upper end of the periurethral cuff 2 there is a fluid outlet channel 4 to regulate the biocompatible fluid in the hydraulic system.
- the mechanical component comprises of two strips of biocompatible mesh extending sideways from the base of the periurethral cuff 2 to form two wings 3. Both wings are transfixed to pelvic fascia and white line of the pelvis using non absorbable material.
- the base of the periurethral cuff 2 and the necks of the balloon reservoirs are reinforced to achieve non kink properties. Both components are made of suitable biocompatible material and the hydraulic system is filled with biocompatible fluid.
- FIG 1 Shows the basic components of the device.
- Figure 2 Shows the basic components seen from Right side.
- Figure 3 Shows a cross section of the device at the proximal end of the device.
- Figure 4 Shows a sagittal section of the female pelvis with the device in situ.
- both balloon reservoirs 1 occupy the retropubic space and extends subperitonealy beyond the upper margin of the symphysis pubis.
- the periurethral cuff 2 surrounds the posterior and lateral aspects of the bladder neck and proximal urethra.
- the wings 3 are transfixed to the endopelvic fascia and to the white line of the pelvis to form a platform.
- the fluid outlet channel 4 is buried subcutaneously in the suprapubic area. The activation of the device could be done later by inserting biocompatible fluid via the fluid outlet channel 4.
- the resting urethral pressure could also be increased to the required levels by adjusting the pressure in the hydraulic system, especially for patients who have higher grades of stress incontinence due to intrinsic sphinteric weakness.
- the periurethral cuff 2 could be lengthened to cover distal parts of the urethra so that increased mtra-abdominal pressure is transmitted to more distal parts of the urethra. This would act as a second line of defence to prevent the escape of any urine which happens to enter the urethra.
- the elevation of the urethra and bladder neck could be achieved by increasing the outer diameter of the periurethral cuff 2.
- this device influences all the known mechanisms of continence by enhancing the transmission of increased intra-abdominal pressure to bladder neck and proximal urethra during stress, prevention of herniation of posterior urethra and bladder neck, and improving the resting urethral pressure. Summation of these mechanisms could ultimately increase the patient's margin for incontinence and push her above the threshold for urinary leakage. The contribution from each component of the device to gain continence could be determined by prior urodynamic investigations. The fluid pressure of the hydraulic system could be readjusted periodically to maintain the optimal resting urethral pressure. The implant could be used as a primary treatment or as a secondary procedure following unsuccessful primary surgery.
Landscapes
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
This implantable continence device consists of a hydraulic and a mechanical component. The hydraulic component comprises two retropubic subperitoneal fluid filled balloon reservoirs (1) which communicates with a periurethral cuff (2) to form a complete hydraulic system. At the upper end of the periurethral cuff (2) there is a fluid outlet channel (4) to regulate the biocompatible fluid in the hydraulic system. The mechanical component comprises of two strips of biocompatible mesh extending sideways from the base of the periurethral cuff (2) to form two wings (3). Both wings are transfixed to pelvic fascia and white line of the pelvis using non absorbable material. The base of the periurethral cuff (2) and the necks of the balloon reservoirs are reinforced to achieve non kink properties. Both components are made of suitable biocompatible material and the hydraulic system is filled with biocompatible fluid. This device improves both resting and stress urethral pressure profile and prevents herniation of bladder neck and proximal urethra during the periods of increased intra-abdominal pressure.
Description
DEVICE FOR GENUINE STRESS INCONTINENCE IN THE FEMALE
This device relates to an implant for the treatment of genuine stress urinary incontinence in the female.
Stress incontinence is urine loss that occurs when sudden increase in intra-abdominal pressure force urine past the urethral sphincter mechanism. This usually occurs during conditions of physical activity which stress the bladder outlet to such a degree that it can no longer remain closed, resulting a momentary urine loss. This is a common and distressing condition.
The two major factors responsible for stress incontinence are loss of support of the proximal urethra and bladder neck which produces hypermobility of these structures and results in stress incontinence due to bladder neck displacement during physically stressful conditions and intrinsic sphincter weakness which may lead to stress incontinence. These factors usually coexist in the same patient.
At present various surgical procedures are being carried out for the treatment of genuine stress incontinence in the female. The objectives of surgery are to restore the pelvic floor so that hypermobility of the bladder neck during stress is minimized and to cause some degree of outflow resistance in the urethra. The results of the surgical procedures are good. However, the long term results are poor as restored pelvic floor 'falls' back to previous state due to plastic properties of pelvic fascia and paraurethral tissues.
This implantable continence device consists of a hydraulic and a mechanical component. The hydraulic component comprises of two retropubic subperitoneal fluid filled balloon reservoirs 1 which communicates with a periurethral cuff 2 to form a complete hydraulic system. At the upper end of the periurethral cuff 2 there is a fluid outlet channel 4 to regulate the biocompatible fluid in the hydraulic system. The mechanical component comprises of two strips of biocompatible mesh extending sideways from the base of the periurethral cuff 2 to form two wings 3. Both wings are transfixed to pelvic fascia and white line of the pelvis
using non absorbable material. The base of the periurethral cuff 2 and the necks of the balloon reservoirs are reinforced to achieve non kink properties. Both components are made of suitable biocompatible material and the hydraulic system is filled with biocompatible fluid.
The design of the device is further described with reference to the accompanying drawings.
Figure 1 Shows the basic components of the device.
Figure 2 Shows the basic components seen from Right side.
Figure 3 Shows a cross section of the device at the proximal end of the device.
Figure 4 Shows a sagittal section of the female pelvis with the device in situ.
When properly implanted both balloon reservoirs 1 occupy the retropubic space and extends subperitonealy beyond the upper margin of the symphysis pubis. The periurethral cuff 2 surrounds the posterior and lateral aspects of the bladder neck and proximal urethra. The wings 3 are transfixed to the endopelvic fascia and to the white line of the pelvis to form a platform. The fluid outlet channel 4 is buried subcutaneously in the suprapubic area. The activation of the device could be done later by inserting biocompatible fluid via the fluid outlet channel 4.
During the periods of stress, increased intra-abdominal pressure is directly transmitted to the balloon reservoirs 1 which transmits the pressure to the bladder neck and the proximal urethra via the hydraulic system to periurethral cuff 2 resulting in improved stress urethral pressure profile.
During the periods of stress, there is reflex contraction of the pelvic floor which transmits the contraction force along the wings 3 causing a resultant upward counterforce that prevents herniation of the bladder neck and proximal urethra.
The resting urethral pressure could also be increased to the required levels by adjusting the pressure in the hydraulic system, especially for patients who have higher grades of stress incontinence due to intrinsic sphinteric weakness.
The periurethral cuff 2 could be lengthened to cover distal parts of the urethra so that increased mtra-abdominal pressure is transmitted to more distal parts of the urethra. This would act as a second line of defence to prevent the escape of any urine which happens to enter the urethra. In addition the elevation of the urethra and bladder neck could be achieved by increasing the outer diameter of the periurethral cuff 2.
Thus, this device influences all the known mechanisms of continence by enhancing the transmission of increased intra-abdominal pressure to bladder neck and proximal urethra during stress, prevention of herniation of posterior urethra and bladder neck, and improving the resting urethral pressure. Summation of these mechanisms could ultimately increase the patient's margin for incontinence and push her above the threshold for urinary leakage. The contribution from each component of the device to gain continence could be determined by prior urodynamic investigations. The fluid pressure of the hydraulic system could be readjusted periodically to maintain the optimal resting urethral pressure. The implant could be used as a primary treatment or as a secondary procedure following unsuccessful primary surgery.
Claims
1. An implantable incontinence device for genuine stress incontinence in the female comprising a hydraulic component and mechanical component, the former having two subperitoneal fluid filled balloon reservoirs 1 which directly communicates with a periurethral cuff 2, means for transmission of increased intra-abdominal pressure to the bladder neck and proximal urethra, and the said mechanical component having two strips of biocompatible mesh forming two wings 3 extending sideways from the base of the periurethral cuff 2 which are transfixed to pelvic fascia means for prevention of hypermobility of the bladder neck and proximal urethra during the periods of increased intra-abdominal pressure.
2. The hydraulic component of the incontinence device as claimed in claim 1 facilitates the transmission of increased intra-abdominal pressure to the bladder neck and proximal urethra resulting in improved stress urethral pressure profile.
3. The fluid pressure in the hydraulic component claimed in claim 1 could be adjusted by regulating the fluid pressure via the fluid channel 4 to have the optimal resting urethral pressure profile.
4. The outer diameter of the periurethral cuff 2 claimed in claim 1 could be increased to improve elevation of the bladder neck and the proximal urethra.
5. The mechanical component of the incontinence device claimed in claim 1 comprises of two strips of biocompatible mesh 3 extending sideways from the base of the periurethral cuff 2 which are transfixed to pelvic fascia transmits the upward counterforce produced by pelvic floor muscles to the base of the periurethral cuff 2, thus preventing hemiation of proximal urethra and bladder neck during the periods of increased intra-abdominal pressure.
6. The subperitoneal fluid filled reservoirs 1, periurethral cuff 2 and wings 3 mentioned in claim 1 could be made in various sizes to suit individual uroiogical requirements.
7. An implantable incontinence device for genuine stress incontinence as herein described and illustrated in the accompanying drawings 1 - 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU29127/97A AU2912797A (en) | 1997-01-15 | 1997-06-10 | Device for genuine stress incontinence in the female |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9700770.2 | 1997-01-15 | ||
| GB9700770A GB2309388A (en) | 1996-01-24 | 1997-01-15 | Implantable device for incontinence relief in the female |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1998031301A1 true WO1998031301A1 (en) | 1998-07-23 |
Family
ID=10806034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB1997/000670 WO1998031301A1 (en) | 1997-01-15 | 1997-06-10 | Device for genuine stress incontinence in the female |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2912797A (en) |
| WO (1) | WO1998031301A1 (en) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2787990A1 (en) * | 1998-12-30 | 2000-07-07 | Medical Research & Management | Prosthesis for correcting female urinary incontinence made in two halves connecting vaginal wall on either side of bladder to abdominal muscles |
| DE10156558A1 (en) * | 2001-11-20 | 2003-05-28 | Helmut Wassermann | Implantable system opening and closing tubular organ has control system reverting automatically to first state |
| FR2838629A1 (en) * | 2002-04-17 | 2003-10-24 | Ct Hospitalier Universitaire Rouen | DEVICE FOR TREATING URINARY INCONTINENCE |
| US6908425B2 (en) | 1999-06-09 | 2005-06-21 | Ethicon Inc. | Surgical instrument and method for treating female urinary incontinence |
| US6932759B2 (en) | 1999-06-09 | 2005-08-23 | Gene W. Kammerer | Surgical instrument and method for treating female urinary incontinence |
| US7025063B2 (en) | 2000-09-07 | 2006-04-11 | Ams Research Corporation | Coated sling material |
| US7083637B1 (en) | 1999-06-09 | 2006-08-01 | Tannhauser Robert J | Method and apparatus for adjusting flexible areal polymer implants |
| US7087065B2 (en) | 2001-10-04 | 2006-08-08 | Ethicon, Inc. | Mesh for pelvic floor repair |
| US7131944B2 (en) | 2002-03-01 | 2006-11-07 | Ethicon, Inc. | Method and apparatus for treating pelvic organ prolapses in female patients |
| US7131943B2 (en) | 2000-03-09 | 2006-11-07 | Ethicon, Inc. | Surgical instrument and method for treating organ prolapse conditions |
| WO2006105053A3 (en) * | 2005-03-28 | 2006-11-30 | Gary M Horndeski | Device and method of weight control via indirect abdominal cavity volume reduction |
| US7156858B2 (en) | 2000-04-20 | 2007-01-02 | Ethicon G.M.B.H. | Implant |
| US7217237B2 (en) | 2001-11-20 | 2007-05-15 | Dieter Jocham | Closing system and electronic control method |
| US7226407B2 (en) | 1999-06-09 | 2007-06-05 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
| US7285086B2 (en) | 2004-07-28 | 2007-10-23 | Ethicon, Inc. | Minimally invasive medical implant and insertion device and method for using the same |
| US7481314B2 (en) | 2005-02-02 | 2009-01-27 | Ethicon, Inc. | Packaging assembly for surgical mesh implants |
| US7527588B2 (en) | 2004-09-15 | 2009-05-05 | Ethicon, Inc. | System and method for surgical implant placement |
| US7658743B2 (en) | 1995-10-09 | 2010-02-09 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
| US8123671B2 (en) | 2005-08-04 | 2012-02-28 | C.R. Bard, Inc. | Pelvic implant systems and methods |
| US8480559B2 (en) | 2006-09-13 | 2013-07-09 | C. R. Bard, Inc. | Urethral support system |
| US8574149B2 (en) | 2007-11-13 | 2013-11-05 | C. R. Bard, Inc. | Adjustable tissue support member |
| US8784296B2 (en) | 2010-09-07 | 2014-07-22 | Coloplast A/S | Angled surgical introducer |
| US8845512B2 (en) | 2005-11-14 | 2014-09-30 | C. R. Bard, Inc. | Sling anchor system |
| WO2014178979A3 (en) * | 2013-05-03 | 2015-02-19 | Cullison James W | Urological implant |
| US9289204B2 (en) | 2008-12-05 | 2016-03-22 | Boston Scientific Scimed, Inc. | Insertion device and method for delivery of a mesh carrier |
| US9301750B2 (en) | 2009-11-03 | 2016-04-05 | Boston Scientific Scimed, Inc. | Device and method for delivery of mesh-based devices |
| US10582923B2 (en) | 2009-04-17 | 2020-03-10 | Boston Scientific Scimed, Inc. | Apparatus for delivering and anchoring implantable medical devices |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3789828A (en) * | 1972-09-01 | 1974-02-05 | Heyer Schulte Corp | Urethral prosthesis |
| EP0207426A2 (en) * | 1985-07-05 | 1987-01-07 | Habley Medical Technology Corporation | Single circuit elastofluidic sphincter |
| WO1988000064A1 (en) * | 1986-07-03 | 1988-01-14 | Habley Medical Technology Corporation | Hypodermically implantable genitourinary prosthesis |
| US4969474A (en) * | 1988-10-11 | 1990-11-13 | Schwarz Gerald R | Incontinence bladder control method and apparatus |
| EP0639355A1 (en) * | 1993-08-21 | 1995-02-22 | RULL, Johann, Dr. med. | Prosthesis for controlling urinary incontinence in women |
-
1997
- 1997-06-10 WO PCT/IB1997/000670 patent/WO1998031301A1/en active Application Filing
- 1997-06-10 AU AU29127/97A patent/AU2912797A/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3789828A (en) * | 1972-09-01 | 1974-02-05 | Heyer Schulte Corp | Urethral prosthesis |
| EP0207426A2 (en) * | 1985-07-05 | 1987-01-07 | Habley Medical Technology Corporation | Single circuit elastofluidic sphincter |
| WO1988000064A1 (en) * | 1986-07-03 | 1988-01-14 | Habley Medical Technology Corporation | Hypodermically implantable genitourinary prosthesis |
| US4969474A (en) * | 1988-10-11 | 1990-11-13 | Schwarz Gerald R | Incontinence bladder control method and apparatus |
| EP0639355A1 (en) * | 1993-08-21 | 1995-02-22 | RULL, Johann, Dr. med. | Prosthesis for controlling urinary incontinence in women |
Cited By (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658743B2 (en) | 1995-10-09 | 2010-02-09 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
| FR2787990A1 (en) * | 1998-12-30 | 2000-07-07 | Medical Research & Management | Prosthesis for correcting female urinary incontinence made in two halves connecting vaginal wall on either side of bladder to abdominal muscles |
| CN100415179C (en) * | 1999-06-09 | 2008-09-03 | 伊西康公司 | Surgical instruments and methods for polymeric implants for modulating a flexible zone |
| US7547316B2 (en) | 1999-06-09 | 2009-06-16 | Ethicon, Inc. | Method and apparatus for adjusting flexible areal polymer implants |
| US6908425B2 (en) | 1999-06-09 | 2005-06-21 | Ethicon Inc. | Surgical instrument and method for treating female urinary incontinence |
| US6932759B2 (en) | 1999-06-09 | 2005-08-23 | Gene W. Kammerer | Surgical instrument and method for treating female urinary incontinence |
| US7083637B1 (en) | 1999-06-09 | 2006-08-01 | Tannhauser Robert J | Method and apparatus for adjusting flexible areal polymer implants |
| US7226407B2 (en) | 1999-06-09 | 2007-06-05 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
| US7121997B2 (en) | 1999-06-09 | 2006-10-17 | Ethicon, Inc. | Surgical instrument and method for treating female urinary incontinence |
| US7131943B2 (en) | 2000-03-09 | 2006-11-07 | Ethicon, Inc. | Surgical instrument and method for treating organ prolapse conditions |
| US7156858B2 (en) | 2000-04-20 | 2007-01-02 | Ethicon G.M.B.H. | Implant |
| US8147478B2 (en) | 2000-09-07 | 2012-04-03 | Ams Research Corporation | Coated sling material |
| US7025063B2 (en) | 2000-09-07 | 2006-04-11 | Ams Research Corporation | Coated sling material |
| US7087065B2 (en) | 2001-10-04 | 2006-08-08 | Ethicon, Inc. | Mesh for pelvic floor repair |
| DE10156558A1 (en) * | 2001-11-20 | 2003-05-28 | Helmut Wassermann | Implantable system opening and closing tubular organ has control system reverting automatically to first state |
| US7217237B2 (en) | 2001-11-20 | 2007-05-15 | Dieter Jocham | Closing system and electronic control method |
| US8480556B2 (en) | 2002-03-01 | 2013-07-09 | Ethicon, Inc. | Method and apparatus for treating pelvic organ prolapses in female patients |
| US7131944B2 (en) | 2002-03-01 | 2006-11-07 | Ethicon, Inc. | Method and apparatus for treating pelvic organ prolapses in female patients |
| US7985173B2 (en) | 2002-03-01 | 2011-07-26 | Ethicon, Inc. | Method and apparatus for treating pelvic organ prolapses in female patients |
| US8460170B2 (en) | 2002-03-01 | 2013-06-11 | Ethicon, Inc. | Method and apparatus for treating pelvic organ prolapses in female patients |
| US7163506B2 (en) | 2002-04-17 | 2007-01-16 | Centre Hospitalier Universitaire De Rouen | Device for the treatment of urinary incontinence |
| AU2003203750B2 (en) * | 2002-04-17 | 2004-11-11 | Centre Hospitalier Universitaire De Rouen | Device for the treatment of urinary incontinence |
| FR2838629A1 (en) * | 2002-04-17 | 2003-10-24 | Ct Hospitalier Universitaire Rouen | DEVICE FOR TREATING URINARY INCONTINENCE |
| EP1354568A3 (en) * | 2002-04-17 | 2010-10-27 | Centre Hospitalier Universitaire de Rouen | Device for the treatment of urinary incontinence |
| US7285086B2 (en) | 2004-07-28 | 2007-10-23 | Ethicon, Inc. | Minimally invasive medical implant and insertion device and method for using the same |
| US7297102B2 (en) | 2004-07-28 | 2007-11-20 | Ethicon, Inc. | Minimally invasive medical implant and insertion device and method for using the same |
| US7527588B2 (en) | 2004-09-15 | 2009-05-05 | Ethicon, Inc. | System and method for surgical implant placement |
| US7481314B2 (en) | 2005-02-02 | 2009-01-27 | Ethicon, Inc. | Packaging assembly for surgical mesh implants |
| WO2006105053A3 (en) * | 2005-03-28 | 2006-11-30 | Gary M Horndeski | Device and method of weight control via indirect abdominal cavity volume reduction |
| US8123671B2 (en) | 2005-08-04 | 2012-02-28 | C.R. Bard, Inc. | Pelvic implant systems and methods |
| US8845512B2 (en) | 2005-11-14 | 2014-09-30 | C. R. Bard, Inc. | Sling anchor system |
| US8480559B2 (en) | 2006-09-13 | 2013-07-09 | C. R. Bard, Inc. | Urethral support system |
| US8574149B2 (en) | 2007-11-13 | 2013-11-05 | C. R. Bard, Inc. | Adjustable tissue support member |
| US9289204B2 (en) | 2008-12-05 | 2016-03-22 | Boston Scientific Scimed, Inc. | Insertion device and method for delivery of a mesh carrier |
| US12021196B2 (en) | 2008-12-05 | 2024-06-25 | Boston Scientific Scimed, Inc. | Insertion device and method for delivery of a mesh carrier |
| US10271937B2 (en) | 2008-12-05 | 2019-04-30 | Boston Scientific Scimed, Inc. | Insertion device and method for delivery of a mesh carrier |
| US10582923B2 (en) | 2009-04-17 | 2020-03-10 | Boston Scientific Scimed, Inc. | Apparatus for delivering and anchoring implantable medical devices |
| US9301750B2 (en) | 2009-11-03 | 2016-04-05 | Boston Scientific Scimed, Inc. | Device and method for delivery of mesh-based devices |
| US8784296B2 (en) | 2010-09-07 | 2014-07-22 | Coloplast A/S | Angled surgical introducer |
| WO2014178979A3 (en) * | 2013-05-03 | 2015-02-19 | Cullison James W | Urological implant |
| US10463466B2 (en) | 2013-05-03 | 2019-11-05 | James W Cullison | Surgical implant |
| US11241302B2 (en) | 2013-05-03 | 2022-02-08 | James W Cullison | Surgical method |
| US9398942B2 (en) | 2013-05-03 | 2016-07-26 | James W Cullison | Surgical implant |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2912797A (en) | 1998-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998031301A1 (en) | Device for genuine stress incontinence in the female | |
| US6786861B1 (en) | Distensible sling for urinary incontinence | |
| EP0553075B1 (en) | Incontinence bladder control apparatus | |
| US5123428A (en) | Laparoscopically implanting bladder control apparatus | |
| US5012822A (en) | Method for controlling urinary incontinence | |
| US5097848A (en) | Incontinence bladder control method and apparatus | |
| US7204801B2 (en) | Pubovaginal support for treating female urinary incontinence | |
| EP2323586B1 (en) | Minimally invasive implant | |
| US11547542B2 (en) | Minimally invasive implant and method | |
| CA2484290A1 (en) | Improved pelvic health implants and methods | |
| US9706985B2 (en) | Adjustable suture restriction system and method | |
| AU2009279635C1 (en) | Pelvic implant and delivery system | |
| GB2309388A (en) | Implantable device for incontinence relief in the female | |
| US7896798B2 (en) | Implant for treatment of male urinary stress incontinence | |
| WO2004096087A1 (en) | Male urethral sphincter prosthesis | |
| AU2015202916B2 (en) | Minimally invasive implant and method | |
| Cardozo et al. | Endoscopically guided bladder neck suspension for continence in paraplegic women with implant driven micturition | |
| ZA200103403B (en) | Distensible sling for urinary incontinence. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: CA |